| RS2051099941 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051103531 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS2051113996 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2051147818 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2051181820 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2051198464 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051210433 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2051221341 |
WNT5A
|
Health Risk |
Likely pathogenic |
— |
| RS2051253130 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2051284935 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2051320206 |
DAG1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS2051339634 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2051361827 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2051380165 |
FECH
|
Health Risk |
Likely pathogenic |
Autosomal erythropoietic protoporphyria, Autosomal erythropoietic protoporphyria |
| RS2051382723 |
HOMER2
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 68, Autosomal dominant nonsyndromic hearing loss 68 |
| RS2051382999 |
HOMER2
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 68, Autosomal dominant nonsyndromic hearing loss 68 |
| RS2051389040 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2051494815 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051495579 |
PLCE1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2051500205 |
BRCA1
|
Health Risk |
Pathogenic |
— |
| RS2051505994 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2051506626 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051507325 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2051507892 |
NARS1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder with microcephaly |
| RS2051510661 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051517323 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2051521489 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2051527389 |
RLBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmentary retinal dystrophy, Newfoundland cone-rod dystrophy |
| RS2051527499 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051530949 |
RLBP1
|
Health Risk |
Pathogenic |
— |
| RS2051550027 |
DNAAF19
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2051568716 |
RLBP1
|
Health Risk |
Likely pathogenic |
RLBP1-related disorder, RLBP1-related disorder |
| RS2051568988 |
RLBP1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS2051588436 |
RLBP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2051605586 |
RLBP1
|
Health Risk |
Pathogenic |
— |
| RS2051634469 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2051636517 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2051680751 |
GFAP
|
Health Risk |
Likely pathogenic |
— |
| RS2051691492 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS2051720336 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1F |
| RS2051753978 |
WWOX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 28 |
| RS2051756247 |
WWOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2051759603 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS2051760352 |
PPARG
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2051764612 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2051791551 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2051792816 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2051819669 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2051825168 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2051830234 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2051832768 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2051852330 |
CREBBP
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2051853150 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental abnormality, CREBBP-related disorder |
| RS2051858178 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051858361 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2051863859 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Intellectual disability |
| RS2051864063 |
HDAC8
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2051867176 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS2051867806 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051868691 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051897517 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS2051898232 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2051906316 |
CREBBP
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2051906390 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2051906420 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051909999 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2051913334 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051924695 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051925024 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051927197 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051929740 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051931458 |
BRCA1
|
Health Risk |
Likely pathogenic |
— |
| RS2051934276 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051937547 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051993500 |
TSPEAR
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2052045274 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2052048258 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2052056277 |
CTCF
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2052056650 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2052063931 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2052068772 |
CTCF
|
Health Risk |
Conflicting classifications of pathogenicity |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2052069695 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2052070559 |
CREBBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2052070776 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2052073167 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2052086981 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2052089346 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2052127299 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2052136913 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related disorder, CTCF-related neurodevelopmental disorder |
| RS2052137160 |
CTCF
|
Health Risk |
Likely pathogenic |
— |
| RS2052153254 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2052159968 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2052160365 |
TMEM94
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare syndromic intellectual disability, Intellectual developmental disorder with cardiac defects and dysmorphic facies |
| RS2052173011 |
BRCA1
|
Health Risk |
Pathogenic |
— |
| RS2052178966 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2052181050 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2052186545 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2052190289 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2052193063 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2052201364 |
TTN;TTN-AS1
|
Health Risk |
Likely pathogenic |
— |